CLINICAL TRIALS PROFILE FOR RADAFAXINE
✉ Email this page to a colleague
Clinical Trials for Radafaxine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00057213 ↗ | An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder | Completed | GlaxoSmithKline | Phase 2 | A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD) |
NCT00057226 ↗ | An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder | Completed | GlaxoSmithKline | Phase 2 | A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD) |
NCT00057239 ↗ | An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder | Completed | GlaxoSmithKline | Phase 2 | A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Radafaxine in Patients with Major Depressive Disorder (MDD) |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Radafaxine
Condition Name
Clinical Trial Locations for Radafaxine
Trials by Country
Clinical Trial Progress for Radafaxine
Clinical Trial Phase
Clinical Trial Sponsors for Radafaxine
Sponsor Name